{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T15:52:38Z","timestamp":1790610758412,"version":"4.1.0"},"reference-count":40,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Science Committee of the Ministry of Education and Science of the Republic of Kazakhstan","award":["AP13268846"],"award-info":[{"award-number":["AP13268846"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathogens"],"abstract":"<jats:p>Latent tuberculosis infection (LTBI) represents a major global health concern as it constitutes the principal reservoir for future tuberculosis (TB) disease. Its identification is particularly important in Bacille Calmette\u2013Gu\u00e9rin (BCG)-vaccinated populations, where cross-reactivity of purified protein derivative limits the specificity of the tuberculin skin test and hampers targeted preventive therapy. Early Mycobacterium tuberculosis antigens encoded within the RD1 region, especially ESAT-6, CFP-10 and TB7.7, have enabled the development of antigen-specific interferon-gamma release assays (IGRAs) and recombinant skin tests with improved BCG-independent specificity. This narrative review integrates and critically appraises current evidence on the immunobiological properties of early and latency-associated antigens, the cellular mechanisms underlying T-cell-dependent immune reactivity, and the diagnostic performance of IGRAs and ESAT-6\/CFP-10-based skin tests, rather than merely summarizing individual studies. Although these platforms rely on different assay principles (in vitro cytokine release versus in vivo delayed-type hypersensitivity), both measure antigen-specific T-cell memory and do not define the biological stage of infection or reliably distinguish latent from incipient or active TB. Across most adult populations, IGRAs demonstrate high specificity and acceptable sensitivity, whereas reduced sensitivity and higher rates of indeterminate results are observed in young children and immunocompromised individuals. ESAT-6\/CFP-10-based skin tests show diagnostic accuracy comparable to IGRAs and may offer operational advantages in resource-limited settings. Latency-associated antigens and host biomarkers such as IP-10, together with multi-analyte immune signatures, represent promising avenues for improving diagnostic sensitivity and prognostic stratification but currently lack sufficient validation for routine clinical use. Overall, RD1-encoded antigens remain central to LTBI immunodiagnosis, while future research should focus on developing stage-resolving and prognostic biomarkers, optimized antigen panels, and standardized interpretive frameworks.<\/jats:p>","DOI":"10.3390\/pathogens15020181","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T13:33:50Z","timestamp":1770384830000},"page":"181","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Early Mycobacterial Antigens in the Immunodiagnosis of Latent Tuberculosis Infection"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5777-3747","authenticated-orcid":false,"given":"Aigul","family":"Utegenova","sequence":"first","affiliation":[{"name":"Department of Microbiology and Virology, Astana Medical University, Astana 010000, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1926-4829","authenticated-orcid":false,"given":"Lazzat","family":"Kassayeva","sequence":"additional","affiliation":[{"name":"Department of Phthisiopulmonology and Radiology, South Kazakhstan Medical Academy, Shymkent 160019, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1141-1564","authenticated-orcid":false,"given":"Bayan","family":"Turdalina","sequence":"additional","affiliation":[{"name":"Department of Pediatric Infectious Diseases, Astana Medical University, Astana 010000, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4967-2804","authenticated-orcid":false,"given":"Aliya","family":"Baiduissenova","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Virology, Astana Medical University, Astana 010000, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2653-9907","authenticated-orcid":false,"given":"Ayaz","family":"Yktiyarov","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Virology, Astana Medical University, Astana 010000, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2395-6032","authenticated-orcid":false,"given":"Marat","family":"Dusmagambetov","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Virology, Astana Medical University, Astana 010000, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evgeni","family":"Sokurenko","sequence":"additional","affiliation":[{"name":"Department of Microbiology, School of Medicine, University of Washington, Seattle, WA 98195, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,2,6]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Agbota, G., Bonnet, M., and Lienhardt, C. (2023). Management of Tuberculosis Infection: Current Situation, Recent Developments and Operational Challenges. Pathogens, 12.","DOI":"10.3390\/pathogens12030362"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Peddireddy, V., Doddam, S.N., and Ahmed, N. (2017). Mycobacterial Dormancy Systems and Host Responses in Tuberculosis. Front. Immunol., 8.","DOI":"10.3389\/fimmu.2017.00084"},{"key":"ref_3","unstructured":"Centers for Disease Control and Prevention (2026, January 01). Clinical Testing Guidance for Tuberculosis: Interferon-Gamma Release Assay (IGRA), Available online: https:\/\/www.cdc.gov\/tb\/hcp\/testing-diagnosis\/interferon-gamma-release-assay.html."},{"key":"ref_4","unstructured":"World Health Organization (WHO) (2024). Global Tuberculosis Report 2024, WHO. Available online: https:\/\/www.who.int\/publications\/i\/item\/9789240101531."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1128\/JCM.02498-16","article-title":"Evaluation of QuantiFERON-TB Gold-Plus in Health Care Workers in a Low-Incidence Setting","volume":"55","author":"Moon","year":"2017","journal-title":"J. Clin. Microbiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e0150025","DOI":"10.1128\/spectrum.01500-25","article-title":"Diagnostic accuracy of the ESAT6-CFP10 skin test for latent tuberculosis infection among jail detainees","volume":"13","author":"Fei","year":"2025","journal-title":"Microbiol. Spectr."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1183\/13993003.01245-2015","article-title":"Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries","volume":"46","author":"Getahun","year":"2015","journal-title":"Eur. Respir. J."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Gong, W., and Wu, X. (2021). Differential Diagnosis of Latent Tuberculosis Infection and Active Tuberculosis: A Key to a Successful Tuberculosis Control Strategy. Front. Microbiol., 12.","DOI":"10.3389\/fmicb.2021.745592"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.cmi.2016.05.006","article-title":"Equal sensitivity of the new generation QuantiFERON-TB Gold plus in direct comparison with the previous test version QuantiFERON-TB Gold IT","volume":"22","author":"Hoffmann","year":"2016","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Houben, R.M., and Dodd, P.J. (2016). The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling. PLoS Med., 13.","DOI":"10.1371\/journal.pmed.1002152"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Jeong, J.H., Shim, S.R., Han, S., Hwang, I., and Ihm, C. (2024). Diagnostic performance of biomarkers for differentiating active tuberculosis from latent tuberculosis: A systematic review and Bayesian network meta-analysis. Front. Microbiol., 15.","DOI":"10.3389\/fmicb.2024.1506127"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"K\u00f6nig Walles, J., Tesfaye, F., Jansson, M., Tolera Balcha, T., Winqvist, N., Kefeni, M., Garoma Abeya, S., Belachew, F., Stureg\u00e5rd, E., and Bj\u00f6rkman, P. (2018). Performance of QuantiFERON-TB Gold Plus for detection of latent tuberculosis infection in pregnant women living in a tuberculosis- and HIV-endemic setting. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0193589"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Khabibullina, N.F., Kutuzova, D.M., Burmistrova, I.A., and Lyadova, I.V. (2022). The Biological and Clinical Aspects of a Latent Tuberculosis Infection. Trop. Med. Infect. Dis., 7.","DOI":"10.3390\/tropicalmed7030048"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1164\/rccm.201501-0199OC","article-title":"T-SPOT.TB Interferon-\u03b3 Release Assay Performance in Healthcare Worker Screening at Nineteen U.S. Hospitals","volume":"192","author":"King","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.ebiom.2015.06.017","article-title":"Dormancy antigens as biomarkers of latent tuberculosis infection","volume":"2","author":"Latorre","year":"2015","journal-title":"EBioMedicine"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Li, K., Yang, C., Jiang, Z., Liu, S., Liu, J., Fan, C., Li, T., and Dong, X. (2019). Quantitative investigation of factors relevant to the T cell spot test for tuberculosis infection in active tuberculosis. BMC Infect. Dis., 19.","DOI":"10.1186\/s12879-019-4310-y"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3385","DOI":"10.2147\/IDR.S470963","article-title":"Specific Cytokines Analysis Incorporating Latency-Associated Antigens Differentiates Mycobacterium tuberculosis Infection Status: An Exploratory Study","volume":"17","author":"Li","year":"2024","journal-title":"Infect. Drug Resist."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"115892","DOI":"10.1016\/j.diagmicrobio.2023.115892","article-title":"Convolutional neural network based on T-SPOT.TB assay promoting the discrimination between active tuberculosis and latent tuberculosis infection","volume":"105","author":"Luo","year":"2023","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1128\/jb.178.5.1274-1282.1996","article-title":"Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis","volume":"178","author":"Mahairas","year":"1996","journal-title":"J. Bacteriol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"781","DOI":"10.15789\/1563-0625-BIR-2289","article-title":"Body immunological reactivity in opiomania","volume":"23","author":"Kulmukanova","year":"2021","journal-title":"Med. Immunol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"739","DOI":"10.3855\/jidc.21027","article-title":"QuantiFERON-TB Gold Plus for Screening and Monitoring Latent Tuberculosis Infection in Spondyloarthritis Patients","volume":"19","author":"Ozsoy","year":"2025","journal-title":"J. Infect. Dev. Ctries."},{"key":"ref_22","first-page":"525","article-title":"Performance of the T-SPOT.TB test in patients with indeterminate QuantiFERON-TB Gold Plus results: Proposal for an algorithm for the diagnosis of Latent Tuberculosis Infection","volume":"32","author":"Pagnoncelli","year":"2024","journal-title":"Le. Infez. Med."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Carranza, C., Pedraza-Sanchez, S., de Oyarzabal-Mendez, E., and Torres, M. (2020). Diagnosis for Latent Tuberculosis Infection: New Alternatives. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.02006"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.tube.2018.06.005","article-title":"Evaluation of IP-10 in Quantiferon-Plus as biomarker for the diagnosis of latent tuberculosis infection","volume":"111","author":"Petrone","year":"2018","journal-title":"Tuberculosis"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1046\/j.1365-2958.2002.03237.x","article-title":"Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti","volume":"46","author":"Pym","year":"2002","journal-title":"Mol. Microbiol."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Druszczynska, M., Seweryn, M., Wawrocki, S., Pankowska, A., Kulbachko, A., Jurczak, M., and Kowalewska-Pietrzak, M. (2025). Interferon (IFN)-gamma (\u03b3) inducible protein 10 (IP-10) in the diagnosis of latent and active tuberculosis in Bacille Calmette Guerin (BCG)-vaccinated pediatric population. PLoS ONE, 20.","DOI":"10.1371\/journal.pone.0314400"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"11948","DOI":"10.1038\/s41598-017-10773-5","article-title":"Circulating Mycobacterium tuberculosis DosR latency antigen-specific, polyfunctional, regulatory IL10+ Th17 CD4 T-cells differentiate latent from active tuberculosis","volume":"7","author":"Rakshit","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_28","first-page":"55","article-title":"C-Tb Skin Test: A Step Toward Tuberculosis Eradication","volume":"6","author":"Reddy","year":"2024","journal-title":"Pediatr. Inf. Dis."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S2213-2600(16)30436-2","article-title":"TESEC Working Group Safety and efficacy of the C-Tb skin test to diagnose Mycobacterium tuberculosis infection, compared with an interferon \u03b3 release assay and the tuberculin skin test: A phase 3, double-blind, randomised, controlled trial","volume":"5","author":"Ruhwald","year":"2017","journal-title":"Lancet Respir. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"559","DOI":"10.18093\/0869-0189-2023-33-4-559-567","article-title":"Skin test based on Mycobacterium tuberculosis antigens (ESAT-6 and CFP-10) for the detection of tuberculosis infection in world practice","volume":"33","author":"Russkikh","year":"2023","journal-title":"Pulmonologiya"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Yang, Y., Wang, H.J., Hu, W.L., Bai, G.N., and Hua, C.Z. (2022). Diagnostic Value of Interferon-Gamma Release Assays for Tuberculosis in the Immunocompromised Population. Diagnostics, 12.","DOI":"10.3390\/diagnostics12020453"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Yoo, I.Y., Lee, J., Choi, A.R., Jun, Y.H., Lee, H.Y., Kang, J.Y., and Park, Y.-J. (2021). Comparative Evaluation of Standard E TB-Feron ELISA and QuantiFERON-TB Gold Plus Assays in Patients with Tuberculosis and Healthcare Workers. Diagnostics, 11.","DOI":"10.3390\/diagnostics11091659"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Sholeye, A.R., Williams, A.A., Loots, D.T., Tutu van Furth, A.M., van der Kuip, M., and Mason, S. (2022). Tuberculous Granuloma: Emerging Insights From Proteomics and Metabolomics. Front. Neurol., 13.","DOI":"10.3389\/fneur.2022.804838"},{"key":"ref_34","unstructured":"World Health Organization (2018). Latent Tuberculosis Infection: Updated and Consolidated Guidelines for Programmatic Management, WHO. Available online: https:\/\/apps.who.int\/iris\/handle\/10665\/260233."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Wu, Y., Xiong, Y., Zhong, Y., Liao, J., and Wang, J. (2024). Role of dormancy survival regulator and resuscitation-promoting factors antigens in differentiating between active and latent tuberculosis: A systematic review and meta-analysis. BMC Pulm. Med., 24.","DOI":"10.1186\/s12890-024-03348-4"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1093\/cid\/ciab472","article-title":"Sensitivity, Specificity, and Safety of a Novel ESAT6-CFP10 Skin Test for Tuberculosis Infection in China: 2 Randomized, Self-Controlled, Parallel-Group Phase 2b Trials","volume":"74","author":"Xu","year":"2022","journal-title":"Clin. Infect. Dis."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Nalukwago, S., Thiel, B., Chervenak, K., Namuganga, A., Malone, L.L., Nsereko, M., Boom, W.H., and Mayanja-Kizza, H. (2025). Evaluation of QuantiFERON TB gold plus among TB household contacts in high incidence settings. BMC Infect. Dis., 25.","DOI":"10.1186\/s12879-025-10812-x"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Yuan, Y., Xia, L., Wu, Q., Liu, X., and Lu, S. (2023). Utility of recombinant fusion protein ESAT6-CFP10 skin test for differential diagnosis of active tuberculosis: A prospective study. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1162177"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/CM9.0000000000001858","article-title":"Mycobacterium tuberculosis latency-associated antigen Rv1733c SLP improves the accuracy of differential diagnosis of active tuberculosis and latent tuberculosis infection","volume":"135","author":"Zhang","year":"2022","journal-title":"Chin. Med. J."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"101416","DOI":"10.1016\/j.lanepe.2025.101416","article-title":"Diagnostic accuracy and predictive value of the QuantiFERON-TB gold plus assay for tuberculosis in immunocompromised individuals: A prospective TBnet study","volume":"57","author":"Sester","year":"2025","journal-title":"Lancet Reg. Health Eur."}],"container-title":["Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-0817\/15\/2\/181\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T12:34:55Z","timestamp":1770899695000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-0817\/15\/2\/181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,6]]},"references-count":40,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["pathogens15020181"],"URL":"https:\/\/doi.org\/10.3390\/pathogens15020181","relation":{},"ISSN":["2076-0817"],"issn-type":[{"value":"2076-0817","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,6]]}}}